Background. Tobacco use is the leading preventable cause of disease and death in the United States. Among racial and ethnic minorities, disparities in tobacco use, knowledge of health risks and treatment resources, and access to and utilization of treatment contribute to a disproportionate disease burden from tobacco use. Furthermore, racial and ethnic minorities have been underrepresented within tobacco treatment studies.
INTRODUCTION
Despite major advances in tobacco control and treatment, tobacco use remains the leading preventable cause of disease and death in the United States. 1 Tobacco use is responsible for one in five deaths, accounting for approximately 443,600 annual premature deaths between 2000 and 2004. 2, 3 Cigarette smoking is a major cause of heart, cerebrovascular, and lung diseases, and accounts for approximately 30% of all cancers. 1 Following decades of declining smoking prevalence in the United States, tobacco use in the general population appears to be reaching a plateau at approximately 20%. 4 Decline in smoking prevalence is not universal across all subpopulations of smokers, and smoking rates for certain groups remain high (e.g., some racial/ ethnic minorities, individuals with low socioeconomic status, individuals with psychiatric comorbidities). 4, 5 Smoking prevalence varies greatly based on racial/ethnic group, and often based on gender within group, as shown in Table 1 , with some subgroups demonstrating rates of smoking exceeding 40%. The four major racial/ethnic groups in the United States (AfricanAmericans, Hispanic/Latinos, American Indian/Alaska Natives, and AsianAmericans) account for almost 33% of the current population (12.2%, 15.4%, 0.8%, and 4.4%, respectively). 6 By 2050, almost half of the U.S. population will be African-American (15%), Latino (21%), American Indian/ Alaska Native (1.1%), or Asian-American (11%). Addressing tobacco use among growing racial and ethnic minority populations is a critical public health priority.
Although the majority of smokers want to stop smoking, minority smokers are less likely to receive advice to stop smoking, to use recommended treatment to aid cessation, or to be successful in achieving or maintaining abstinence. [9] [10] [11] [12] [13] [14] [15] Within racial and ethnic minority populations, factors such as lower socioeconomic status, language barriers, reduced access to health care, and lower rates of insurance coverage among some groups contribute to reduced access to treatment. 16 Notable differences between minorities and whites in smoking prevalence, patterns of use, and treatment outcomes have been well documented elsewhere 10, [17] [18] [19] [20] and contribute to the need to evaluate treatment interventions within minority smokers. 4, [21] [22] [23] Furthermore, within minority populations, significant differences exist in prevalence, patterns of use, and factors associated with use. Indeed, heterogeneity within these broadly defined groups encompasses multiple cultural factors, acculturation, community affiliation, and country of origin, which adds further complexity to understanding tobacco use and treatment. Benowitz 24 proposed that because genetic, sociocultural, and pharmacological determinants of smoking may differ by racial and ethnic group, smoking cessation interventions may produce varying outcomes in smokers of different groups; therefore, empirical evaluation of specific interventions across different groups is warranted.
Recommendations for the treatment of tobacco dependence are found in the United States Public Health Service Clinical Practice Guideline, Treating Tobacco Use and Dependence: 2008 Update. 25 The guideline reflects the review of more than 8700 research articles to identify effective, experimentally validated treatments and clinical practices. Specific recommendations are provided with the goal of assisting clinicians and health care systems to effectively identify and treat all tobacco users. Key recommendations include universal identification of all tobacco users and the treatment of smokers who want to quit using both counseling and pharmacotherapy to aid cessation, unless contraindicated. Guideline recommendations apply to smokers of racial and ethnic minorities, with the acknowledgement of limited inclusion of minority smokers within treatment research. Importantly, the guideline specifically calls for additional research on effectiveness of smoking cessation interventions among racial/ethnic minority populations, efficacy of culturally adapted vs. generic interventions (see also Borrelli 5 ), factors salient to treatment, and identification of barriers to enhance access and efficacy of intervention for these groups. 25 To contribute to this call, the goal of the current paper is to provide a review of published studies examining tobacco treatment interventions among ethnic and minority smokers in the United States, building upon previous literature reviews. 26, 27 
METHODS
Articles were identified using a Medline search of smoking cessation interventions on the racial/ethnic minority populations of interest in the United States published from 1985 through 2009. Additional sources utilized for searches included PsycINFO, Social Science Citation Index, conference abstracts, and personal files and contacts, as well as author searches from articles found in earlier searches. Search terms used to identify smoking cessation studies included smoking cessation, tobacco use intervention and treatment, and smoking clinical trials. Population-specific search terms used included African-American, Black, Hispanic-American, Latino, MexicanAmerican, Native American, Alaskan Native, American Indian, Asian-American, and Pacific Islander. To be selected for inclusion a study had to meet the following criteria: (1) have been conducted in adults 18 years or older, (2) have targeted one or more U.S. ethnic minority groups or have at least 10% of study participants come from ethnic minority groups, and (3) have reported smoking cessation as an outcome. Articles that met these criteria were reviewed by authors to extract relevant information outlined in Table 2.
RESULTS
The broad initial search yielded approximately 900 publications, but most were not tobacco use treatment studies. Of identified treatment studies, most did not include 10% racial or ethnic minority smokers, and a few did not report smoking abstinence as an outcome. A total of 64 studies met our inclusion criteria and are presented in this review: 28 included a primary focus on African-Americans, 10 focused on Latinos, 4 focused on Native Americans, and 3 focused on AsianAmerican smokers. An additional 19 studies reported samples including participants from more than one minority group. Table 2 presents an overview of study design, intervention, and outcomes arranged by primary racial/ethnic group and year of publication. The study designs of the reviewed publications included 36 individually randomized, 4 clusterrandomized, 14 quasi-experimental, and 10 cohort studies. Assessment of demographics, smoking history, and social and psychological correlates of smoking behavior varied across studies, as did duration of intervention and 41, 50, 53, 58, 88 or to a nonmedication control condition, 45, 54, 91 and one randomized trial examined nicotine patch compared to nicotine nasal spray. 81 Although interventions including nicotine gum increased abstinence among AfricanAmerican smokers in the Lung Health Study, 34 no significant benefit of nicotine gum was found among exclusively or predominantly African-American samples in three other studies. 50, 53, 91 In contrast, evaluation of the nicotine patch demonstrated efficacy with samples of African-American 41, 45, 54 and Latino 58 smokers and with a multiethnic sample including 12% ethnic minority smokers. 88 Within these nicotine patch studies, abstinence rates in the treatment conditions ranged from 22% to 49% at end of treatment 41, 58, 88 to 17% to 30% at long-term follow-up at or beyond 6 months. 41, 45, 54 One randomized study of nicotine patch vs. nasal spray among a racially diverse sample of smokers demonstrated similar overall 6-month abstinence rates across the full sample (29% for nicotine patch and 25% for nicotine nasal spray), with a relative benefit from use of nasal spray demonstrated among ethnic minority smokers (sample including 27% African-Americans, 3% Latinos, and 2% Asian-Americans). 81 There were no randomized controlled studies of nicotine lozenge, nicotine inhaler, combination NRT, or NRT combined with bupropion. Other studies of African-American, 48, 49, 55 Latino, 62, 63, 67 Alaskan Native, 68 ChineseAmerican, 74 and multiethnic samples 90 have demonstrated the feasibility of patch or other NRT use within cohort studies or randomized evaluation of behavioral interventions.
Nonnicotine Pharmacotherapy. Four randomized placebo-controlled studies evaluated bupropion in samples of African-American 46 or ethnically diverse smokers. 85, 86, 92 One small multiethnic study of female smokers including 25% African-Americans and 5% Latinas found no significant effect for bupropion at 12 months. 92 In contrast, three larger studies found significant effects of bupropion relative to placebo, demonstrating abstinence 85 and 30%. 86 However, neither of the varenicline studies directly reported efficacy of bupropion or varenicline for minority smokers alone. 85, 86 One final study evaluated silver acetate lozenge vs. placebo in a sample of both white and African-American smokers and found no main effect of treatment at 12 months. 32 
Behavioral Interventions
The majority of behavioral interventions included multiple components involving some combination of brief or extended counseling, group counseling, telephone counseling, written materials, or other educational materials.
Culturally Adapted Interventions.
Of studies targeting a single racial or ethnic group, most incorporated some elements of intervention defined by the investigators as culturally tailored. These components included written materials (described below); video for African-American, 33, 36, 94 Latino, 60 and American Indian 70 smokers; audio components for African-American 33 and Latino 59 smokers; and television and radio messages for Latino 57 and Vietnamese-American 72,73 smokers. One study directly evaluated a nontailored intervention using telephone counseling and written materials to an equivalent intervention with tailored telephone counseling and tailored written materials 39 for African-American smokers; although no significant difference in abstinence outcomes occurred at 6-month follow-up, participants reported statistically greater abstinence in the tailored group (25%) compared to standard intervention (15%) at 12 months. Another study provided nicotine patch therapy to African-American smokers and evaluated adjunct self-help materials comparing culturally sensitive video and guide to nontailored video and guide. 55 Although 6-month abstinence was similar between the culturally tailored (18%) and standard (14%) interventions (p . .05), a significant treatment by racial identity interaction suggested standard materials may be less effective for smokers with stronger racial identity. 55 Printed Materials. Of the 64 studies reviewed here, 32 (50%) included some form of printed smoking cessation materials. In most cases, studies incorporating written materials into an intervention provided these materials to all smokers across treatment conditions. In addition to standard stopsmoking materials published by the American Lung Association, American Cancer Society, and National Cancer Institute, written materials have been specifically developed for AfricanAmerican, Latino, and Asian smokers involving language-appropriate content for non-English speaking smokers. The tailored guide Pathways to Freedom included culturally specific images and content related to AfricanAmerican smoking and health and demonstrated benefit relative to standard materials in two multicomponent studies 39, 94 described above. Pérez-Stable and colleagues developed and evaluated a culturally tailored and language appropriate Spanish-language guide, Guía para Dejar de Fumar, which has been used widely within Latino interventions. 56, [59] [60] [61] 64 Another Spanish-language guide, Tomando control de su Vida, was developed specifically to address mood management within treatment: this manual demonstrated significant efficacy in promoting abstinence in Latino smokers when combined with the Guía (25% abstinence at 6 months), relative to using the Guía alone (9%). 59 Tobacco use treatment materials have been developed for American Indians and are currently under evaluation. 95 Special written materials have also been included within interventions for pregnant smokers, such as Time for a Change: A Program for Healthy Moms and Babies 77 and Quitting for You 2.
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Counseling. Theoretical Approach. The theoretical approach reflected within counseling was not defined consistently across studies. 53, 74 and supportive counseling. 28, 60, 92 One study examined case management. 52 Two studies directly compared motivational interviewing (MI) and HE counseling with smokers interested in quitting and willing to use pharmacotherapy to aid cessation, and provided 6-month outcomes. 53, 74 Within a sample of African-American smokers, HE doubled quit rates relative to MI (17% vs. 9%, biochemically verified abstinence). 53 In contrast, a sample of ChineseAmericans found a doubling effect of MI over HE (67% vs. 32%, self-reported abstinence). 74 Reasons for this notable difference in findings are unclear.
Content of Counseling. Content of counseling varied among brief advice, single-session counseling, and multiple-session counseling. Interventions varied among face-toface, combined face-to-face and telephone follow-up counseling, group counseling, combined individual and group counseling, and telephone counseling only. Although two studies examined brief advice alone compared to usual care and found no increase in abstinence, 42, 51 brief advice within a multicomponent intervention and interventions with more extensive counseling commonly produced increased abstinence relative to usual care in African-American smokers. 29, 43, 44 Two studies reported higher abstinence rates for individuals who completed more sessions of counseling: one study included African-American smokers 50 and the second included Latino smokers. 64 The majority of studies did not describe treatment engagement or adherence (e.g., the proportion of counseling sessions completed). Although social support was included within many interventions, social support as a specific component of intervention was not directly tested.
Telephone Counseling. All five studies evaluating telephone counseling supported the efficacy of this mode of individual counseling. Telephone counseling outperformed printed smoking cessation materials alone among African-American 43 and a mixed sample of smokers. 82 Tailored telephone counseling produced higher rates of abstinence relative to standard telephone counseling. 39 In an evaluation of Latino smokers using the telephone quitline, Wetter and colleagues 64 found extended intervention up to four calls produced significantly higher abstinence (27%) compared to a single call (21%), providing additional evidence for a dose-response relationship in behavioral intervention. Further support for state telephone quitlines was provided by Maher and colleagues, 90 who found similarly strong 3-month abstinence outcomes across racial/ethnic groups within a diverse sample, with 30% self-reported abstinence among non-Hispanic whites, 33% among Asian/Pacific Islanders, and 35% among AfricanAmericans, Latinos, and American Indian/Alaska Natives. Other studies also incorporated telephone counseling following initial face-to-face intervention. 28, 38, 46, 53, 61, 62 Group Counseling. Interventions involving group therapy were largely effective. Of five controlled studies of group therapy compared to minimal intervention, four (80%) demonstrated significant benefit including long-term efficacy (6 months-5 years) in AfricanAmerican smokers 29, 45, 54 and shortterm efficacy (8 weeks) among Latinos. 60 One study with AfricanAmerican smokers showed no added benefit of group counseling within a multicomponent intervention. 33 Four other studies involving group therapy for all participants demonstrated notable rates of abstinence following treatment for Latino, 63 Alaska Native, 68 and mixed samples of smokers. 81, 88 Lay Health Providers/Promotores. Community volunteers, lay health providers, or promotores de salud were utilized within multicomponent interventions for African-American, 47 Latino, 57, 61 American Indian, 70 and mixed ethnic samples of smokers. 80 Woodruff and colleagues 61 evaluated promotoresdelivered counseling combined with culturally tailored written materials and video for Latino smokers compared with referral to the state telephone counseling quitline and found significantly greater abstinence at 3 months within the intervention group (21%) relative to control (9%). Although the other interventions did not directly test the efficacy of lay providers per se, these studies provided examples of considering community members to enhance cultural relevance within roles of identifying and recruiting smokers, conducting data collection, delivering intervention, and/or facilitating retention.
Novel Behavioral Intervention Components. Four studies examined smoking cessation interventions alone or with an added experimental treatment component and found mixed results as follows. Biomarker feedback regarding genetic susceptibility to lung cancer produced significantly higher rates of 6-month term abstinence in AfricanAmerican smokers when combined with nicotine patch and self-help materials compared to the intervention without feedback (19% vs. 10%), 48 although this significant difference was not sustained at 12 months (15% vs. 10%). No significant elevation in abstinence was seen among smokers in a multiethnic sample receiving feedback about their CO levels in concert with MI compared to a standard intervention. 83 Within another multiethnic sample, the addition of exercise to a cognitive behavioral intervention demonstrated significant benefit at 3 months but not at 12 months. 84 Finally, a mood management intervention for Latino smokers significantly increased rates of abstinence at 6 months compared to a culturally tailored intervention alone (25% vs. 9%). 59 
Community-Wide Interventions
Of seven quasi-experimental studies evaluating community-wide smoking cessation interventions, 34, 37, 40, 54, 57, 72, 73 five (71%) demonstrated a significant impact on abstinence. Three of four studies within African-American communities found significant reduction in smoking status relative to comparison communities with interventions extending from 6 to 24 months. 37, 40, 54 Intervention components included mass media, community organizing activities, door-to-door campaigns, smoking cessation classes, and a gospel festival. 37, 40 A culturally tailored intervention targeting African-American women, Sister to Sister, incorporated community health workers with nursedelivered ''empowerment'' group counseling, and provided free nicotine patches for 6 weeks; significant effect of intervention was demonstrated in 28% abstinence at 6 months within the intervention community compared to 6% in the control community. 54 In contrast, one multicomponent smoking cessation intervention for AfricanAmerican smokers found no significant increase in abstinence when compared to an intervention focusing on alternate health behaviors (e.g., diet, exercise). 34 One program for Latino smokers, Programma A Su Salud, combined language and culturally relevant television, radio, and newspaper stories with community volunteers, counseling, and written materials and found 17% abstinence at 2 years to be significantly greater than 7% within a control community, 57 whereas a cohort study found 14% abstinence at 12 months following community-wide intervention including broad distribution of culturally tailored self-help materials. 56 Finally, two similar multicomponent interventions focused on smoking cessation among men in Vietnamese-American communities and found differing outcomes. 72, 73 Both interventions included tailored mass media, community events, and HE materials. One study found no difference between intervention and control communities following a 24-month campaign, 72 whereas a second study that further added student and family activities, physician education, and business events produced higher rates of abstinence among Vietnamese men at 39 months. 73 The investigators suggested the potential importance of broadening the reach of intervention and continuing community efforts over time.
Special Considerations
Differential Participant Response Within Treatment. Seven studies demonstrated racial or ethnic differences in response to intervention. 29, 32, 38, 49, 77, 79, 87 Two large studies 79 and relative to Latino and African-American smokers in a second study, 87 and the second study also demonstrated Asian-American smokers had relatively poorer abstinence outcomes. 87 In two studies intervening with pregnant female smokers, AfricanAmerican women demonstrated higher rates of abstinence following intervention relative to white smokers 29 and Latina smokers. 77 African-American smokers were more likely to quit smoking, relative to white smokers, in a study of brief nurse-delivered counseling 38 and a randomized study of silver acetate lozenge. 32 In contrast, one study of nicotine patch with or without adjuvant counseling found rates of abstinence among African-American smokers (9%) to be significantly lower than those of white smokers (14%) at 12 months. 49 Two other studies found notable within-group differences in treatment response. Bock and colleagues 62 evaluated nicotine patch and brief counseling for Latino and non-Latino white smokers and found significantly greater self-reported abstinence among lessacculturated Latinos (21%) compared to bicultural Latino (9%) or white (13%) smokers. Furthermore, among evaluation of African-American and Latino smokers who received individual clinical treatment for tobacco use, non-menthol users were twice as likely to be abstinent at 6 months compared to menthol users. 93 Short-Term and Long-Term Abstinence. Some interventions demonstrated significant effects on short-term (e.g., 3 months) but not long-term (e.g., 12 months) abstinence in samples of African-American, 32, 48 Latino, 60 and ethnically diverse groups of smokers. 84 These mixed outcomes demonstrate the need for intervention components to prevent relapse and facilitate long term smoking behavior change.
DISCUSSION
This review provided a summary of two decades of tobacco use treatment evaluation among racial and ethnic minority smokers in the United States. Although ethnic minority smokers remain underrepresented within smoking cessation research, the literature clearly supports the feasibility of recruiting and treating minority smokers within both clinical trials and community interventions. Within the existing research, African-Americans have the greatest representation, with fewer studies evaluating Latino smokers, and limited attention given to Native American and Asian-American smokers. Overall, the literature broadly supports the Clinical Practice Guidelines' recommendations for (1) intervention for all tobacco users, with application of pharmacotherapy and counseling to promote abstinence, and (2) needed research to further establish evidencebased treatments for racial and ethnic minority smokers. 25 Given the limited evaluation of tobacco use treatment among minority smokers and the need to further establish evidence-based interventions, additional research focused on specific racial and ethnic groups is called for. Because smoking prevalence, smoking initiation, patterns of tobacco use, and factors associated with smoking behavior and behavior change differ across segments and subgroups of our population, 17 clinicians and investigators cannot assume treatments are appropriate and effective for all smokers. 22 Until investigators have the means available to ''deconstruct racial and ethnic differences into genetic vs. social vs. pharmacologic differences, and their interactions,'' empirical evaluation of the efficacy of different interventions across racial and ethnic subgroups is required. 24 Evaluation of environmental, sociocultural, psychological, and biological factors that contribute to tobacco use and treatment response, 96 and identification of protective or risk factors related to treatment engagement and outcome, would contribute to enhanced interventions for all smokers.
The current review provided support for pharmacotherapy to aid cessation, with evidence for nicotine patch use for Latino smokers, and nicotine patch, nicotine nasal spray, and bupropion for African-American smokers. To date, studies of nicotine gum use in African-American smokers demonstrated no efficacy. Other studies demonstrated acceptability of use of nicotine patch among Alaska Natives and Chinese-Americans, nicotine lozenge, and gum for Latinos. Studies also demonstrated acceptability of bupropion for Latinos as well as acceptability of bupropion and varenicline among ethnically diverse samples including small numbers of African-American and Asian smokers. Although counseling and multicomponent behavioral interventions have demonstrated mixed results, the overall body of literature supports counseling and written materials to aid smoking abstinence. Positive outcomes were seen within individual and group counseling interventions. Interventions commonly included behavioral strategies, support, and general relapse prevention. Further evidence supported use of written materials and telephone counseling across all groups. In summary, these findings support tobacco use treatment intervention for minority smokers.
Given the potential for pharmacotherapy to double or triple rates of abstinence within treatment, 25 careful evaluation of pharmacotherapy is needed. Within pharmacotherapy studies, explicit description of the medication protocol is needed, including type of pharmacotherapy, dose, and length of treatment. No studies have previously tested the efficacy of nicotine lozenge, nicotine inhaler, combined use of NRT, combined use of NRT and bupropion, or use of varenicline in any ethnic minority sample. Studies have not evaluated efficacy of nicotine gum, nasal spray, or bupropion in Latino, American Indian, Alaska Native, Asian, or Pacific Islander samples. Furthermore, given efficacy of the nicotine patch demonstrated in African-American and Latino smokers, it also merits examination within Native American and Asian-American smokers. These studies could include examination of sociocultural, psychological, and biological factors contributing to treatment efficacy within groups. Furthermore, for products demonstrating efficacy, effectiveness studies are also needed to examine acceptability, utilization, and potential barriers to use within different populations.
The degree to which cultural adaptation of evidence-based interventions is necessary or preferable remains unclear. Language-specific adaptation is clearly needed for non-English speaking populations. Although many studies support the implementation of other culturally tailored components within interventions, only two studies specifically evaluated nontailored vs. tailored interventions. Culturally tailored intervention may be more or less acceptable or effective given individual differences within groups, and these within-group differences should also be considered during evaluation. 55, 97, 98 Borrelli 5 articulated considerations for cultural adaptation of evidence-based treatment for smoking cessation, and further supported the call for theorybased intervention to improve our understanding of the treatment process and smoking behavior change. In addition, innovative formative research within specific populations will provide further contributions to advancing treatment.
The primary outcome examined within this review was smoking abstinence. Variations in outcome assessment, follow-up, and method of analysis restricted comparison of findings across studies. Indeed, when examining abstinence rates reported within this review, consideration should be given to methodology used in assessing abstinence within the original studies. This review found instances of undefined self-reported abstinence, limited collection of biochemical verification of smoking abstinence, and exclusion of participants lost to followup within outcome analyses. The Society for Research on Nicotine and Tobacco subcommittees on abstinence outcome measures 99 and biochemical verification 100 developed recommendations for outcome assessment. The recommended primary outcome was prolonged abstinence (defined as continuous abstinence following a 2-week grace period), using 7-and 30-day point prevalence as a secondary outcome; 6 and/or 12 month followup are recommended to examine long-term treatment effects. 99 Recommended validation of self-reported smoking abstinence included expired breath CO and cotinine in plasma, urine, or saliva. Recently, new biochemical standards were proposed for distinguishing differences in smoking status for specific racial and ethnic groups. 101 Collection of biochemical samples may not be feasible for some large-population/low-intensity interventions. However, it is recommended that both self-report and biochemical data be reported when possible to allow comparisons of outcomes. 100 Finally, careful reporting of participants who drop out or are lost to follow-up, combined with intent-totreat analysis, would further promote comparisons of findings across studies.
Reporting other outcomes related to smoking behavior could contribute to evaluation of treatment effects and further our understanding of how to promote behavior change. Secondary outcomes to consider include treatment engagement/adherence, number of quit attempts, 39 change in smoking level (e.g., reduction in cigarettes per day), 59 and changes in intention or motivation 33, 34, 44 or other cognitive processes that may contribute to behavior change. 46 Future research must articulate the racial/ethnic characteristics of study participants, and studies including multiethnic cohorts are recommended to report outcomes for each group. Studies should clearly define the smoking characteristics of study participants. Most studies within this review specifically defined participants by smoking level (cigarettes per day), others did not report smoking level, and few reported smoking frequency (e.g., daily or nondaily use). Only a handful of studies specifically reported inclusion of smokers who used fewer than 10 cigarettes per day, 59, 83, 84, 91 only one study focused intervention specifically for light smokers, 53 and no study evaluated treatment for nondaily smokers. Few studies reported type of tobacco use, specifically menthol use. Given the repeated finding that menthol users have poorer treatment outcomes, 93, 102, 103 assessment and reporting of menthol use is important. Given the prevalence of light and nondaily smoking and menthol use within some minority populations, there is an essential need for innovative research in these areas. Finally, limited data exist on minority populations' use of chewing tobacco, snuff, cigars, and other forms of tobacco. In effort to reduce tobacco-related morbidity and mortality and to treat nicotine dependence, other forms of tobacco must not be overlooked.
Overall utilization of effective treatment to aid cessation is low in the United States, 20 but is particularly low among racial and ethnic minority smokers. 10 Barriers to treatment include availability of services, knowledge of smoking cessation resources, health care access, cost, and availability of language-specific resources. Therefore, in addition to identifying effective interventions, efforts are needed to increase implementation of interventions, availability and awareness of treatment resources, and demand for treatment among minority smokers.
The current evaluation is limited to four primary ethnic minority groups in the United States. Additional evaluation of tobacco use treatment interventions is needed for other understudied populations, including adolescent and elderly smokers; lesbian, gay, bisexual, and transgender groups; economically disadvantaged smokers; and smokers with specific medical or psychiatric comorbidities, with the goal of enhancing treatment for these smokers.
In summary, individuals from racial and ethnic minority populations are interested in stopping smoking and willing to participate in treatment. Studies generally supported behavioral counseling and pharmacotherapy to aid cessation. However, additional research to establish effective treatment is needed for all groups, including African-American smokers, and special attention is warranted for Latino, Native American, and Asian groups. The need for cultural adaptation of intervention to maximize efficacy merits further evaluation. Taken as a whole, the findings from this review provide a mandate to health care providers to intervene with and treat minority smokers, and to investigators to conduct further research to establish effective interventions for minority smokers and to increase the representation of minority smokers within tobacco treatment research. The health risks of continued tobacco use and benefits of smoking cessation provide an ethical imperative for treating racial and ethnic minorities, with the goals of promoting health and decreasing tobacco-related health disparities. Further research to enhance treatment for minority populations will advance these goals.
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